Dr. Wang is in charge of innovative drug R&D strategy and foreign strategic cooperation of Simcere, leading cell and gene therapy segment directly and preceding the preparation of Shanghai Simnova Biotechnology Co.,Ltd and Boston Innovation Center.

Dr. Wang owns years of experience in the field of cellular immune therapy. As the corresponding author, Prof. Wang has published more than one hundred papers in international top magazine and a number of invention patents have been authorized. Currently, he is responsible for the development of multiple CAR-T and CAR-NK anti-tumor cell drugs.

Dr. Wang received doctorate in Chemical Engineering, California Institute of Technology, and engaged in postdoctoral research. Before joining Simcere, Prof. Wang was director of the Center for Immune Engineering at the University of Southern California, Tenure Professor in the Department of Chemical Engineering and Materials Science and Zohrab A. Kaprielian Professor in the School of Engineering. Besides, he was also a professor of the Department of Biomedical Engineering and Department of Pharmacology and Pharmacy.